WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

2.06.25

Wilson Sonsini Advises Protex AI on $36 Million Series B
On January 29, 2025, Protex AI, the global leader in AI-driven workplace safety technology, announced it has secured an oversubscribed $36 million Series B funding round. The round was led by Hedosophia with participation from Salesforce Ventures and existing investors Elkstone, firstminute capital, Notion Capital, and Playfair. Wilson Sonsini Goodrich & Rosati advised Protex AI on the transaction.

This latest investment comes as Protex AI accelerates its expansion in the U.S. to revolutionize worker safety on a global scale through computer vision and AI. This funding round will allow the company to expand its U.S. presence and focus on bringing top-tier talent into the fold to continue driving innovation and enabling Protex AI’s growth.
Client Highlights

12.03.24

Wilson Sonsini Advises 9fin on $50 Million Funding to Invest in AI and Pursue U.S. Expansion
On December 2, 2024, 9fin, the AI-powered analytics platform for debt capital markets, announced it has raised $50 million in a Series B round led by Highland Europe, with participation from existing investors Spark Capital, Redalpine, Seedcamp, 500 Startups, and Ilavska Vuillermoz Capital. The new funding will enable 9fin to invest further in its market-leading AI technology, grow its analytics team, and accelerate its expansion in the U.S.
Client Highlights

10.07.24

Firm Advises Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on Constructive Bio’s $58 Million Series A
On September 24, 2024, Constructive Bio, a pioneering synthetic genomics company, announced that it has secured $58 million in the first close of its Series A financing, bringing the total amount raised by the company to date to $75 million. The round was led by Ahren Innovation Capital, OMX Ventures, and Paladin Capital Group with participation from Fine Structure Ventures, +ND Capital, and Abcam-founder Jonathan Milner. Wilson Sonsini Goodrich & Rosati advised Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on the transaction.
Client Advisories

9.04.24

“Would You Please Repeat That in English?” Unpacking the Major Differences in Venture Capital Practices in the UK and the U.S.
As U.S.-based venture capital funds have become an increasingly significant source of capital for UK start-up and scale-up companies, the negotiation of terms often give rise to gaps in expectations and market norms between the two jurisdictions.  
Client Highlights

9.07.22

Firm Advises PolyAI on $40 Million Series B Financing
On September 7, 2022, PolyAI, a leading provider of enterprise voice assistants, raised $40 million in a Series B funding round led by Georgian with participation from Twilio Ventures as well as existing investors Khosla Ventures, Point72 Ventures, and Amadeus Capital Partners. This latest financing brings PolyAI’s total funding to $70 million. Wilson Sonsini Goodrich & Rosati advised PolyAI on the transaction.
Client Highlights

6.08.22

Wilson Sonsini Advises Multiverse on $220 Million Series D Funding
On June 8, 2022, Multiverse, a UK start-up that works with organizations to develop apprenticeships and helps source promising, diverse candidates to fill those roles, announced it has raised $220 million in its Series D funding round. The financing was co-led by StepStone Group, and returning investors Lightspeed Venture Partners and General Catalyst. The round brings Multiverse's total funding to date to over $400 million. Wilson Sonsini Goodrich & Rosati advised Multiverse on the transaction.
Client Highlights

5.10.22

Wilson Sonsini Advises Paddle on $200 Million Series D
On May 10, 2022, Paddle, the provider of a complete payments infrastructure for SaaS companies, announced it had raised $200 million in Series D equity and debt financing at a valuation of $1.4 billion, making it the UK's latest unicorn. Led by KKR, a leading global investment firm, with participation from existing investors FTV Capital, 83North, Notion Capital, Kindred Capital, and debt financing from Silicon Valley Bank, the investment brings the total Paddle has raised to date to $293 million. Wilson Sonsini Goodrich & Rosati advised Paddle on the transaction, in collaboration with Taylor Wessing.  

Paddle will use this investment to strengthen the growth of its platform and to meet the market opportunity that exists for a complete payment infrastructure provider for software companies globally, which will assist in enabling them to scale and sell their products faster, with less risk and lower costs.
Client Highlights

1.20.22

Wilson Sonsini Advises ONI on $75 Million Series B
On January 20, 2022, ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, announced the closing of a $75 million Series B funding round. The round was led by ARCH Venture Partners and Casdin Capital with participation from Section 32, ARTIS Ventures, Vertical Venture Partners, Axon Ventures, and private investors, including Paul Conley. Existing investors, including Oxford Science Enterprises, also participated in the round. Wilson Sonsini Goodrich & Rosati advised ONI on the transaction.
Client Highlights

1.12.22

Wilson Sonsini Advises Checkout.com on $1 Billion Series D Financing
On January 12, 2022, Checkout.com, a global payment solutions provider, announced a $1 billion Series D funding round, giving the company a valuation of $40 billion. Primary investors include Altimeter, Dragoneer, Franklin Templeton, GIC, Insight Partners, the Qatar Investment Authority, Tiger Global, The Oxford Endowment Fund, and another large west coast mutual fund management firm. Wilson Sonsini Goodrich & Rosati advised Checkout.com on the fundraise, together with Allen & Overy and Carey Olsen.
Client Highlights

10.18.21

Wilson Sonsini Advises Current Health on Acquisition by Best Buy
On October 12, 2021, Best Buy announced it had signed an agreement to acquire Current Health, a leading care-at-home technology platform that brings together remote patient monitoring, telehealth, and patient engagement into a single solution for healthcare organizations. Wilson Sonsini Goodrich & Rosati represented Current Health in the acquisition.
Client Highlights

9.30.21

Firm Advises ContractPodAi on $115 Million Series C
On September 30, 2021, ContractPodAi, the provider of the AI-powered contract lifecycle management led ‘One Legal Platform’, announced a $115 million Series C investment headed by SoftBank Vision Fund 2. Existing investor, Eagle Proprietary Investments, also doubled down on their previous investments from ContractPodAi’s Series A and Series B rounds. Wilson Sonsini Goodrich & Rosati advised ContractPodAi in the transaction.
Client Highlights

9.28.21

Wilson Sonsini Advises Multiverse on $130 Million Series C Funding
On September 28, 2021, Multiverse, a UK start-up that works with organizations to develop apprenticeships and helps source promising, diverse candidates to fill those roles, announced a $130 million Series C funding led by D1 Capital Partners and BOND.

The proceeds from the new funding will enable Multiverse to continue to drive growth and adoption across the U.S. and UK, ensuring that it is reaching talented individuals from a range of backgrounds while working with the top companies and delivering outstanding education. The company has grown nearly four times its size in one year and now has a community of over 5,000 apprentices and alumni. Earlier in September, Multiverse opened its U.S. headquarters in New York, six months after launching in the United States.

The London-based Wilson Sonsini team that advised Multiverse on the financing included Michael Labriola, Dan Glazer, Diviya Padman, Alex Moffitt, and Kailey Paglia and was supported by Taylor Wessing LLP.

For more information, please see Multiverse’s announcement.
  • 1
  • 2
  • 3
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.